Severe Infections May Be Common In Patients Infected With HIV/HCV Taking Directing-Acting Antivirals, Study Suggests.

Infectious Disease Advisor (10/15, Dellabella) reports researchers found that “in patients with HIV/hepatitis C virus (HCV)-coinfection who receive oral direct-acting antiviral agents (DAAs) severe infections are relatively common.” The findings were pub...